{
    "organizations": [],
    "uuid": "837ba04bce75e85d1c4e9450f6391fcd1da02617",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biocryst-announces-initiation-of-a/brief-biocryst-announces-initiation-of-apex-s-long-term-safety-trial-of-bcx7353-in-patients-with-hereditary-angioedema-idUSFWN1QI0UP",
    "ord_in_thread": 0,
    "title": "BRIEF-BioCryst Announces Initiation Of APeX-S Long-Term Safety Trial Of BCX7353 In Patients With Hereditary Angioedema",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Biocryst Pharmaceuticals Inc:\n* BIOCRYST ANNOUNCES INITIATION OF THE APEX-S LONG-TERM SAFETY TRIAL OF BCX7353 IN PATIENTS WITH HEREDITARY ANGIOEDEMA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T19:15:00.000+02:00",
    "crawled": "2018-03-01T21:01:01.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "biocryst",
        "pharmaceutical",
        "inc",
        "biocryst",
        "announces",
        "initiation",
        "safety",
        "trial",
        "bcx7353",
        "patient",
        "hereditary",
        "angioedema",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}